Bank Of America Corp C4 Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,768,499 shares of CCCC stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,768,499

Previous 1,855,158 4.67%

Holding current value

$11.4 Million

Previous $15.2 Million 46.09%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.05 - $8.1 $350,968 - $701,937	-86,659 Reduced 4.67%	1,768,499 $8.17 Million
Q1 2024 May 15, 2024	BUY	$5.3 - $11.0 $954,323 - $1.98 Million	180,061 Added 10.75%	1,855,158 $15.2 Million
Q4 2023 Feb 14, 2024	BUY	$1.18 - $6.03 $1.94 Million - $9.9 Million	1,641,428 Added 4875.19%	1,675,097 $9.46 Million
Q2 2023 Aug 14, 2023	SELL	$2.75 - $3.77 $49,002 - $67,177	-17,819 Reduced 34.61%	33,669 $92,000
Q1 2023 May 12, 2023	SELL	$3.1 - $9.02 $445,370 - $1.3 Million	-143,668 Reduced 73.62%	51,488 $161,000
Q4 2022 Feb 10, 2023	BUY	$5.42 - $10.24 $303,351 - $573,122	55,969 Added 40.21%	195,156 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $623,738 - $991,922	77,676 Added 126.28%	139,187 $1.22 Million
Q2 2022 Aug 12, 2022	SELL	$5.06 - $26.46 $213,871 - $1.12 Million	-42,267 Reduced 40.73%	61,511 $463,000
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $42,078 - $69,949	2,105 Added 2.07%	103,778 $2.52 Million
Q4 2021 Feb 08, 2022	BUY	$29.39 - $46.86 $2.35 Million - $3.75 Million	80,122 Added 371.78%	101,673 $3.27 Million
Q3 2021 Nov 15, 2021	SELL	$35.91 - $50.5 $457,996 - $644,077	-12,754 Reduced 37.18%	21,551 $963,000
Q2 2021 Sep 13, 2021	BUY	$30.39 - $42.18 $1.04 Million - $1.45 Million	34,305 New	34,305 $1.3 Million

Others Institutions Holding CCCC

# of Institutions

119

Shares Held

53.8M

Call Options Held

331K

Put Options Held

145K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $315M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp C4 Therapeutics, Inc. Transaction History